ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 152 filers reported holding ARRAY BIOPHARMA INC in Q2 2015. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $834,000 | +89.1% | 65,159 | +81.8% | 0.01% | +100.0% |
| Q3 2017 | $441,000 | +38.7% | 35,847 | -5.9% | 0.00% | +33.3% |
| Q2 2017 | $318,000 | -9.4% | 38,079 | -2.9% | 0.00% | 0.0% |
| Q1 2017 | $351,000 | -40.5% | 39,216 | -41.5% | 0.00% | -40.0% |
| Q4 2016 | $590,000 | +30.2% | 67,073 | 0.0% | 0.01% | +25.0% |
| Q3 2016 | $453,000 | +86.4% | 67,073 | 0.0% | 0.00% | +100.0% |
| Q2 2016 | $243,000 | +22.7% | 67,073 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $198,000 | -42.4% | 67,073 | -17.8% | 0.00% | -33.3% |
| Q4 2015 | $344,000 | -8.5% | 81,591 | -1.0% | 0.00% | 0.0% |
| Q3 2015 | $376,000 | -74.6% | 82,449 | -59.8% | 0.00% | -72.7% |
| Q2 2015 | $1,478,000 | +2916.3% | 205,033 | +1807.3% | 0.01% | – |
| Q2 2014 | $49,000 | – | 10,750 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 16,618,776 | $146,079,000 | 12.59% |
| BVF INC/IL | 4,986,186 | $43,829,000 | 8.81% |
| First Light Asset Management, LLC | 1,000,361 | $8,793,000 | 3.86% |
| Crosspoint Capital Strategies, LLC | 463,005 | $4,070,000 | 3.62% |
| Consonance Capital Management LP | 2,723,471 | $23,912,000 | 2.63% |
| KOPP INVESTMENT ADVISORS LLC | 219,926 | $1,933,000 | 2.04% |
| SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $7,911,000 | 2.00% |
| Orbimed Advisors | 16,088,800 | $141,421,000 | 1.80% |
| Cormorant Asset Management, LP | 1,150,000 | $10,109,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,073,680 | $18,227,000 | 1.26% |